Cargando…

Is Ki-67 a prognostic factor for post-operation survival in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma?

Detalles Bibliográficos
Autores principales:	Li, Changcan, He, Zhangyuting, Hu, Yingchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641129/ https://www.ncbi.nlm.nih.gov/pubmed/36388026 http://dx.doi.org/10.21037/tcr-22-1664

Ejemplares similares

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.
por: Railo, M., et al.
Publicado: (1993)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Baak, Jan P. A., et al.
Publicado: (2005)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Silvestrini, Rosella
Publicado: (2005)

Comment on: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium
por: dos Santos Martins, Thiago Gonçalves
Publicado: (2021)

DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma
por: Cao, Yi, et al.
Publicado: (2017)

Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision-Making: A New Way of Counting
por: Bulloni, Matteo, et al.
Publicado: (2021)

Molecular subtyping of ependymoma and prognostic impact of Ki-67
por: Lim, Ka Young, et al.
Publicado: (2021)

Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma
por: Yang, Xihua, et al.
Publicado: (2023)

In Response to “Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making: A New Way of Counting”
por: Belderbos, Robert A., et al.
Publicado: (2021)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Pathological prognostic factors for post-resection survival in patients with hepatocellular carcinoma associated with non-alcoholic fatty liver disease
por: D’Silva, Mizelle, et al.
Publicado: (2021)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Gastrointestinal Stromal Tumor and Ki-67 as a Prognostic Indicator
por: Kadado, Kevin J, et al.
Publicado: (2022)

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018)

Bi-directional roles of IRF-1 on autophagy diminish its prognostic value as compared with Ki67 in liver transplantation for hepatocellular carcinoma
por: Zhang, Hai-Ming, et al.
Publicado: (2016)

Eyeing non-alcoholic fatty liver disease: The noninvasive way
por: Gude, Dilip
Publicado: (2011)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Intra-operative cytodiagnosis of primary ovarian choriocarcinoma with Ki67 immunoexpression
por: Kar, Asaranti, et al.
Publicado: (2015)

Correlationship between Ki67, VEGF, and p53 and Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
por: Zhang, Xia, et al.
Publicado: (2021)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Noninvasive Imaging for the Evaluation of Non-Alcoholic Fatty Liver Disease Spectrum
por: Liu, Qianjiao, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease, diabetes medications and blood pressure
por: Ilias, Ioannis, et al.
Publicado: (2021)

Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Jeong, Seogsong, et al.
Publicado: (2023)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

The prognostic significance of p63 and Ki-67 expression in myoepithelial carcinoma
por: Jiang, You-Hua, et al.
Publicado: (2012)

Diagnostic and Prognostic Value Of Ki67 Proliferation Fraction in Serous Effusions
por: Schönherr, Alexandra, et al.
Publicado: (2004)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

Ki-67 is a prognostic marker for hormone receptor positive tumors
por: Pérez-López, M. E., et al.
Publicado: (2016)

Ki67 as a prognostic factor of craniopharyngioma’s recurrence in paediatric population
por: Moszczyńska, Elżbieta, et al.
Publicado: (2020)

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2020)

Prognostic and Clinicopathological Value of Ki-67 in Melanoma: A Meta-Analysis
por: Liu, Qixin, et al.
Publicado: (2021)

Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
por: Meng, Yu, et al.
Publicado: (2022)

Prognostic value of Ki-67 in nasopharyngeal carcinoma: a meta-analysis
por: Li, Yulin, et al.
Publicado: (2021)

Intermittent fasting and immunomodulatory effects: A systematic review
por: He, Zhangyuting, et al.
Publicado: (2023)

Prognostic Value of Ki67 in Patients with Stage 1–2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor
por: Jiang, Peng, et al.
Publicado: (2020)

A nomogram incorporating Ki67 to predict survival of acral melanoma
por: Du, Yu, et al.
Publicado: (2023)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Multipronged Approach to Assess Risk Factors for Non-alcoholic Fatty Liver Disease
por: Hidrus, Aizuddin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uk7e9g5ep17k218c9i5q6a318o